Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Asset disposition Inv. presentation Cert. of designation Appointed director
|
Bionik Laboratories Corp. (BNKL)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/13/2022 |
4
| Russo Richard Paul Jr (CEO and President) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Granted 60,000 options to buy
@ $0.302, valued at
$18.1k
|
|
06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/21/2022 |
4
| Gaston-Dreyfus Remi (10% Owner) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Converted 77,887 shares
@ $9.5, valued at
$739.9k
|
|
12/13/2021 |
4
| Gaston-Dreyfus Remi (10% Owner) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Exercised 115,759 shares
@ $0 Exercised 5,000 shares
@ $0 Exercised 115,759 options to buy
@ $3.595, valued at
$416.2k
Exercised 5,000 options to buy
@ $3.16, valued at
$15.8k
|
|
12/13/2021 |
4
| Gaston-Dreyfus Remi (10% Owner) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Granted 61,256 shares
@ $0 |
|
12/13/2021 |
4
| Gaston-Dreyfus Remi (10% Owner) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Bought 135,560 shares
@ $0 |
|
10/18/2021 |
4
| Wass Loren W. (See Remarks) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Granted 55,000 options to buy
@ $2.1, valued at
$115.5k
|
|
10/15/2021 |
4
| Russo Richard Paul Jr (CFO and Interim CEO) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Granted 80,000 options to buy
@ $2.1, valued at
$168k
|
|
04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/31/2021 |
4
| MALONE PETER GERALD (Director) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Bought 26,430 shares
@ $0 |
|
11/27/2019 |
4
| Gaston-Dreyfus Remi (10% Owner) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Converted 4,997 shares
@ $0 Converted 4,997 options to buy
@ $0 |
|
10/03/2019 |
4
| Gaston-Dreyfus Remi (10% Owner) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Converted 76,225 shares
@ $6.8, valued at
$518.3k
|
|
08/28/2019 |
4
| Gaston-Dreyfus Remi (10% Owner) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Bought 106,358 shares
@ $3.76, valued at
$399.9k
|
|
08/08/2019 |
4
| AUBERTON-HERVE ANDRE-JACQUES (Director) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Granted 115,759 options to buy
@ $3.59, valued at
$415.6k
|
|
07/30/2019 |
4
| Dusseux Eric Michel (CEO) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Granted 115,759 options to buy
@ $3.59, valued at
$415.6k
|
|
07/30/2019 |
4
| MARTIN JOSEPH R (Director) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Granted 19,293 options to buy
@ $3.59, valued at
$69.3k
|
|
07/30/2019 |
4
| Gaston-Dreyfus Remi (Director) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Granted 115,759 options to buy
@ $3.59, valued at
$415.6k
|
|
07/30/2019 |
4
| MALONE PETER GERALD (Director) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Granted 19,293 options to buy
@ $3.59, valued at
$69.3k
|
|
07/30/2019 |
4
| Thevenon Audrey (Director) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Granted 19,293 options to buy
@ $3.59, valued at
$69.3k
|
|
07/30/2019 |
4
| Matine Charles (Director) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Granted 19,293 options to buy
@ $3.59, valued at
$69.3k
|
|
06/04/2019 |
4
| AUBERTON-HERVE ANDRE-JACQUES (Director) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Granted 7,500 options to buy
@ $3.16, valued at
$23.7k
|
|
06/04/2019 |
4
| Thevenon Audrey (Director) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Granted 5,000 options to buy
@ $3.16, valued at
$15.8k
|
|
06/04/2019 |
4
| Gaston-Dreyfus Remi (Director) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Granted 5,000 options to buy
@ $3.16, valued at
$15.8k
|
|
06/04/2019 |
4
| Dusseux Eric Michel (CEO) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Granted 110,855 options to buy
@ $3.16, valued at
$350.3k
|
|
06/04/2019 |
4
| MALONE PETER GERALD (Director) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Granted 5,000 options to buy
@ $3.16, valued at
$15.8k
|
|
06/04/2019 |
4
| MARTIN JOSEPH R (Director) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Granted 5,000 options to buy
@ $3.16, valued at
$15.8k
|
|
06/04/2019 |
4
| MARKOW LESLIE NADENE (CFO) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Granted 7,400 options to buy
@ $3.16, valued at
$23.4k
|
|
06/04/2019 |
4
| Matine Charles (Director) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Granted 5,000 options to buy
@ $3.16, valued at
$15.8k
|
|
04/09/2019 |
4
| AUBERTON-HERVE ANDRE-JACQUES (Director) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Converted 81,492 shares
@ $3.8875, valued at
$316.8k
|
|
04/05/2019 |
4
| Gaston-Dreyfus Remi (10% Owner) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Converted 197,234 shares
@ $3.8875, valued at
$766.7k
|
|
07/26/2018 |
4
| Gaston-Dreyfus Remi (10% Owner) has filed a Form 4 on Bionik Laboratories Corp.
Txns:
| Converted 43,468,547 shares
@ $0.0513, valued at
$2.2M
|
|
|
|
|